語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Herb-Drug Combinations = A New Complementary Therapeutic Strategy /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Herb-Drug Combinations / by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble.
其他題名:
A New Complementary Therapeutic Strategy /
作者:
Hemaiswarya, Shanmugam.
其他作者:
Doble, Mukesh.
面頁冊數:
XV, 276 p. 1 illus.online resource. :
Contained By:
Springer Nature eBook
標題:
Medicinal Chemistry. -
電子資源:
https://doi.org/10.1007/978-981-19-5125-1
ISBN:
9789811951251
Herb-Drug Combinations = A New Complementary Therapeutic Strategy /
Hemaiswarya, Shanmugam.
Herb-Drug Combinations
A New Complementary Therapeutic Strategy /[electronic resource] :by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble. - 1st ed. 2022. - XV, 276 p. 1 illus.online resource.
Chapter 1. Introduction -- Chapter 2. Measuring Herb-drug interaction and Synergy -- Chapter 3. Herb-Herb and Food-drug interactions -- Chapter 4. Pharmacokinetic interactions in synergistic herb-drug combinations -- Chapter 5. Antagonistic Herb-drug interactions -- Chapter 6. Synergistic Herb-drug interactions against bacteria -- Chapter 7. Synergistic herb-drug interactions against tuberculosis -- Chapter 8. Synergistic herb-drug interactions against viral diseases -- Chapter 9. Synergistic herb interactions with cardiovascular drugs -- Chapter 10. Synergistic herb interactions with anticancer drugs -- Chapter 11. Synergistic herb interactions with antidiabetic drugs -- Chapter 12. Synergistic herb-drug interactions against obesity -- Chapter 13. Synergistic Herb-Drug Interactions in Neurological Disorders -- Chapter 14. Synergistic Herb-drug interactions with antifungal and antiparasitic agents -- Chapter 15. Computational methods to study herb-drug interactions -- Chapter 16. Regulations and guidelines involving synergistic plant-drug interactions -- Chapter 17. Clinical trials on synergistic herb-drug interactions -- Chapter 18. QFuture prospects on synergistic herb-drug interactions -- Chapter 19. Conclusion.
Plant extracts or their pure natural constituents have been used traditionally for thousands of years for treating diseases with considerable success in India and other Asian countries. In addition, they have also been used as complements or supplements with conventional medicine. This book discusses the latest research in the application of combination therapy, namely herbs and drugs, in the treatment of a range of communicable and non-communicable diseases to achieve a synergistic effect. This synergy may help in reducing the amount of drug, its toxicity, side effects, and development of resistance as well as improve its efficacy. The book also discusses the pharmacodynamic and pharmacokinetic parameters, experimental tools to determine the impact of combination, computational approaches to identify synergy, statistical analysis of data, and clinical and regulatory issues. The book is useful for researchers in the fields of pharmacology, pharmacy and medicinal chemistry and those working in pharmaceutical and nutraceutical industries. This book could open up new strategies to focus on multiple targets to combat complex diseases unlike the single targeted drugs that are being currently marketed by the pharmaceuticals industries.
ISBN: 9789811951251
Standard No.: 10.1007/978-981-19-5125-1doiSubjects--Topical Terms:
668872
Medicinal Chemistry.
LC Class. No.: RM300-666
Dewey Class. No.: 615
Herb-Drug Combinations = A New Complementary Therapeutic Strategy /
LDR
:03878nam a22003975i 4500
001
1084065
003
DE-He213
005
20221005112339.0
007
cr nn 008mamaa
008
221228s2022 si | s |||| 0|eng d
020
$a
9789811951251
$9
978-981-19-5125-1
024
7
$a
10.1007/978-981-19-5125-1
$2
doi
035
$a
978-981-19-5125-1
050
4
$a
RM300-666
072
7
$a
MMG
$2
bicssc
072
7
$a
MED071000
$2
bisacsh
072
7
$a
MKG
$2
thema
082
0 4
$a
615
$2
23
100
1
$a
Hemaiswarya, Shanmugam.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
1229038
245
1 0
$a
Herb-Drug Combinations
$h
[electronic resource] :
$b
A New Complementary Therapeutic Strategy /
$c
by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble.
250
$a
1st ed. 2022.
264
1
$a
Singapore :
$b
Springer Nature Singapore :
$b
Imprint: Springer,
$c
2022.
300
$a
XV, 276 p. 1 illus.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
505
0
$a
Chapter 1. Introduction -- Chapter 2. Measuring Herb-drug interaction and Synergy -- Chapter 3. Herb-Herb and Food-drug interactions -- Chapter 4. Pharmacokinetic interactions in synergistic herb-drug combinations -- Chapter 5. Antagonistic Herb-drug interactions -- Chapter 6. Synergistic Herb-drug interactions against bacteria -- Chapter 7. Synergistic herb-drug interactions against tuberculosis -- Chapter 8. Synergistic herb-drug interactions against viral diseases -- Chapter 9. Synergistic herb interactions with cardiovascular drugs -- Chapter 10. Synergistic herb interactions with anticancer drugs -- Chapter 11. Synergistic herb interactions with antidiabetic drugs -- Chapter 12. Synergistic herb-drug interactions against obesity -- Chapter 13. Synergistic Herb-Drug Interactions in Neurological Disorders -- Chapter 14. Synergistic Herb-drug interactions with antifungal and antiparasitic agents -- Chapter 15. Computational methods to study herb-drug interactions -- Chapter 16. Regulations and guidelines involving synergistic plant-drug interactions -- Chapter 17. Clinical trials on synergistic herb-drug interactions -- Chapter 18. QFuture prospects on synergistic herb-drug interactions -- Chapter 19. Conclusion.
520
$a
Plant extracts or their pure natural constituents have been used traditionally for thousands of years for treating diseases with considerable success in India and other Asian countries. In addition, they have also been used as complements or supplements with conventional medicine. This book discusses the latest research in the application of combination therapy, namely herbs and drugs, in the treatment of a range of communicable and non-communicable diseases to achieve a synergistic effect. This synergy may help in reducing the amount of drug, its toxicity, side effects, and development of resistance as well as improve its efficacy. The book also discusses the pharmacodynamic and pharmacokinetic parameters, experimental tools to determine the impact of combination, computational approaches to identify synergy, statistical analysis of data, and clinical and regulatory issues. The book is useful for researchers in the fields of pharmacology, pharmacy and medicinal chemistry and those working in pharmaceutical and nutraceutical industries. This book could open up new strategies to focus on multiple targets to combat complex diseases unlike the single targeted drugs that are being currently marketed by the pharmaceuticals industries.
650
2 4
$a
Medicinal Chemistry.
$3
668872
650
2 4
$a
Drug Safety and Pharmacovigilance.
$3
1064651
650
2 4
$a
Complementary and Alternative Medicine.
$3
1366573
650
0
$a
Medicinal chemistry.
$3
1253747
650
0
$a
Pharmacovigilance.
$3
1163244
650
0
$a
Alternative medicine.
$3
583495
650
0
$a
Pharmacy.
$3
582411
650
0
$a
Pharmacology.
$3
583819
700
1
$a
Doble, Mukesh.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
582422
700
1
$a
Prabhakar, Pranav Kumar.
$e
author.
$4
aut
$4
http://id.loc.gov/vocabulary/relators/aut
$3
1390263
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9789811951244
776
0 8
$i
Printed edition:
$z
9789811951268
776
0 8
$i
Printed edition:
$z
9789811951275
856
4 0
$u
https://doi.org/10.1007/978-981-19-5125-1
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入